abecarnil has been researched along with Anxiety Neuroses in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tonks, A | 1 |
| Gale, C; Oakley-Browne, M | 3 |
| Basile, AS; Lippa, AS; Skolnick, P | 1 |
| Ballenger, JC; Lydiard, RB; Rickels, K | 1 |
| Manfro, GG; Otto, MW; Pollack, MH; Worthington, JJ; Zucker, BG | 1 |
| Bystritsky, A; Small, GW | 1 |
| Aufdembrinke, B | 1 |
| Aufdembrinke, B; DeMartinis, N; Rickels, K | 1 |
| Ballenger, JC; Cook, B; Garvey, M; Goodard, AW; Lydiard, B; McDonald, S; Noyes, R; Patin, J; Rickels, K; Woods, SW | 1 |
| Ballenger, JC; McDonald, S; Noyes, R; Patin, J; Rickels, K; Singer, J; Sussman, N; Woods, S | 1 |
5 review(s) available for abecarnil and Anxiety Neuroses
| Article | Year |
|---|---|
Treating generalised anxiety disorder.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Carbolines; Cognitive Behavioral Therapy; Humans; Hydroxyzine; Kava; Relaxation Therapy | 2003 |
Generalised anxiety disorder.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Carbolines; Cognitive Behavioral Therapy; Humans; Hydroxyzine | 2003 |
Anxioselective anxiolytics: can less be more?
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepinones; Carbolines; Clinical Trials as Topic; Fluorobenzenes; GABA-A Receptor Agonists; Humans; Indoles; Pyrroles; Quinolones; Triazoles | 2004 |
Generalised anxiety disorder.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Carbolines; Cognitive Behavioral Therapy; Humans; Hydroxyzine; Kava; Phytotherapy | 2004 |
Generalised anxiety disorder.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Carbolines; Cognitive Behavioral Therapy; Humans; Hydroxyzine | 2005 |
7 trial(s) available for abecarnil and Anxiety Neuroses
| Article | Year |
|---|---|
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Topics: Adolescent; Adult; Aged; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Carbolines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Carbolines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 1997 |
Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Topics: Age Factors; Aged; Anti-Anxiety Agents; Anxiety Disorders; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Carbolines; Double-Blind Method; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Carbolines; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos | 2000 |
The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Carbolines; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1992 |
The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Carbolines; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1991 |